Stryker (NYSE: SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic ...

Stryker (NYSE: SYK) today announced plans to showcase the latest innovations across a handful of its orthopedic product lines.

The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural ...

Think Surgical today announced the first completed cases using the TMINI miniature robotic system with the Stryker Triathlon knee system.

Stryker (NYSE: SYK) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 12.63%. Currently, Stryker has a market capitalization of ...

Medical device maker Stryker Corp. won’t have to defend a proposed class action alleging its employee non-compete agreements violate Washington state law, a federal court said.

Whether through pressure injury prevention, fall prevention, infection prevention or safe patient handling initiatives, Stryker’s mission is to do everything possible to provide the optimal experience ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $426.14, along ...

SYK launches Synchfix EVT, a next-gen ankle fixation system designed to streamline surgery and expand reach into adolescent ...